Kyrok Raises €3.1M to Modernize Pharma Supply Chains

The big picture: Berlin-based industrial AI startup Kyrok has raised €3.1 million in a pre-seed round led by Speedinvest. The company is building an AI operating system for supply chain management tailored to Europe’s pharmaceutical and chemical SMEs, powered by industry-specific AI agents.

Why it matters:

• Legacy Systems: Much of the pharmaceutical and chemical manufacturing industry still relies on outdated systems and institutional knowledge, leading to inefficiencies.
• Market Pressures: Both sectors face increasing pressure from supply chain disruptions, international competition, and workforce demographic shifts.
• Knowledge Preservation: Kyrok’s AI aims to capture critical operational expertise from experienced employees nearing retirement, embedding it into digital processes.

How it works:

• Application Layer: Kyrok’s platform integrates with existing ERP systems, eliminating the need for costly system migrations for SMEs.
• AI Agents: Supply chain teams operate through a single interface where AI agents support and guide workflows, learning from user interactions over time.
• Module Expansion: The initial module focuses on customer service for order intake, with future plans to address production planning, material planning, and procurement.

The catch: The challenge for Kyrok will be overcoming the inherent resistance to change and data integration complexities within highly regulated and traditionally conservative sectors like pharma and chemicals. Ensuring seamless integration with diverse legacy ERP systems across numerous SMEs will be critical for adoption and scalability.